Protective effect of folic acid on cyclosporine-induced bone loss in rats

Transplant International

Volumn 25, Issue 1, 2012, Pages 127-133

  Mohammadi, Alireza ^a   Omrani, Layla ^a   Omrani, Ladan R ^b   Kiani, Farin ^c   Eshraghian, Ahad ^a,c   Azizi, Zabihallah ^a   Omrani, Gholamhossein R ^a,c  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

bone density; bone volume; cyclosporine; folic acid; homocysteine

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; CYCLOSPORIN; FOLIC ACID; HOMOCYSTEINE; OLIVE OIL;

ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ARTICLE; BONE DENSITY; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; EXPERIMENTAL STUDY; MALE; MANDIBLE; NONHUMAN; OSTEOLYSIS; PERIODONTAL LIGAMENT; PRIORITY JOURNAL; RAT;

ANIMAL FEED; ANIMALS; BONE DENSITY; CYCLOSPORINE; FOLIC ACID; HOMOCYSTEINE; IMMUNOSUPPRESSIVE AGENTS; MALE; MODELS, BIOLOGICAL; MODELS, STATISTICAL; RATS; RATS, SPRAGUE-DAWLEY;

EID: 83955162847     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2011.01375.x     Document Type: Article

References (52)

1. Andrews DJ, Cramb R,. Cyclosporin revisions in monitoring guidelines and review of current analytical methods. Ann Clin Biochem 2002; 39 (Pt 5): 424
2. Faerber L, Braeutigam M, Weidinger G, et al. Cyclosporine in severe psoriasis. Results of a meta-analysis in 579 patients. Am J Clin Dermatol 2001; 2: 41.
3. Bendix G, Bjelle A,. Adding low-dose cyclosporin A to parenteral gold therapy in rheumatoid arthritis: a double-blind placebo controlled study. Br J Rheumatol 1996; 35: 1142.
4. Wolinsky JS, Scheinberg LC, Smith CR, et al. Efficacy and toxicity of cyclosporine in chronic progressive multiple sclerosis: a randomized, double-blinded, placebo-controlled clinical trial. Ann Neurol 1990; 27: 591.
5. Burckart GJ, Canafax DM, Yee GC,. Cyclosporine monitoring. Drug Intell Clin Pharm 1986; 20: 649.
6. Spolidorio LC, Spolidorio DM, Holzhausen M,. Effects of long-term cyclosporine therapy on the periodontium of rats. J Periodontal Res 2004; 39: 257.
7. Fu E, Hsieh YD, Nieh S, Wikesjo UM, Liu D,. Effects of cyclosporin A on alveolar bone: an experimental study in the rat. J Periodontol 1999; 70: 189.
8. Fu E, Hsieh YD, Shen EC, Nieh S, Mao TK, Chiang CY,. Cyclosporin-induced gingival overgrowth at the newly formed edentulous ridge in rats: a morphological and histometric evaluation. J Periodontol 2001; 72: 889.
9. Goodman GR, Dissanayake IR, Sodam BR, et al. Immunosuppressant use without bone loss-implications for bone loss after transplantation. J Bone Miner Res 2001; 16: 72.
10. Arnadottir M, Hultberg B, Vladov V, Nilsson-Ehle P, Thysell H,. Hyperhomocysteinemia in cyclosporine-treated renal transplant recipients. Transplantation 1996; 61: 509.
11. Gerdhem P, Ivaska KK, Isaksson A, et al. Associations between homocysteine, bone turnover, BMD, mortality, and fracture risk in elderly women. J Bone Miner Res 2007; 22: 127.
12. Lee SH, Kim MJ, Kim BJ, et al. Hyperhomocysteinemia due to levodopa treatment as a risk factor for osteoporosis in patients with Parkinson's disease. Calcif Tissue Int 2010; 86: 132.
13. Cakir-Ozkan N, Eyibilen A, Ozkan F, Ozyurt B, Aslan H,. Stereologic analysis of bone produced by distraction osteogenesis or autogenous bone grafting in mandible. J Craniofac Surg 2010; 21: 735.
14. Schmid A,. How to use Heidenhains azan staining in insects. Neurosci Lett 1989; 5: 101.
15. Sahin B, Emirzeoglu M, Uzun A, et al. Unbiased estimation of the liver volume by the Cavalieri principle using magnetic resonance images. Eur J Radiol 2000; 73: 679.
16. Roberts N, Puddephat MJ, McNulty V,. The benefit of stereology for quantitative radiology. Br J Radiol 2000; 73: 679.
17. Regeur L, Pakkenberg B,. Optimizing sample design for volume measurement of components of human brain using a stereological method. J Microsc 1989; 155: 113.
18. Roberts N, Garden AS, Cruz-Orive LM, Whitehouse GH, Edwards RH,. Estimation of fetal volume by magnetic resonance imaging and stereology. Br J Radiol 1994; 67: 1067.
19. Genant HK, Cooper C, Poor G, et al. Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporos Int 1999; 10: 259.
20. International Osteoporosis Foundation. The facts about osteoporosis and its impact. International Osteoporosis Foundation Web site. Available at: http://www.osteofound.org/press-centre/fact- sheet.html. [Acccessed 26 July 2005].
21. Burger H, De Laet CEDH, Van Daele PLA, et al. Risk factors for increased bone loss in an elderly population. Am J Epidemiol 1998; 147: 871.
22. Tugwell P, Pincus T, Yocum D, et al. Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. N Engl J Med 1995; 333: 137.
23. Rosmarin DM, Lebwohl M, Elewski BE, Gottlieb AB,. National psoriasis foundation cyclosporine and psoriasis: 2008 National Psoriasis Foundation Consensus Conference. J Am Acad Dermatol 2010; 62: 838.
24. Dehghani SM, Taghavi SA, Eshraghian A, et al. Hyperlipidemia in Iranian liver transplant recipients: prevalence and risk factors. J Gastroenterol 2007; 42: 769.
25. Sass DA, Bowman AR, Yuan Z, Ma Y, Jee WS, Epstein S,. Alendronate prevents cyclosporin A-induced osteopenia in the rat. Bone 1997; 21: 65.
26. Cvetkovic M, Mann GN, Romero DF, et al. The deleterious effects of long-term cyclosporine A, cyclosporine G, and FK506 on bone mineral metabolism in vivo. Transplantation 1994; 57: 1231.
27. Mann GN, Sass DA, Chen HK, et al. Short-term systemic insulin-like growth factor-1 is unable to prevent cyclosporine A-induced osteopenia in the rat. Calcif Tissue Int 1996; 59: 38.
28. Rich GM, Mudge GH, Laffel GL, LeBoff MS,. Cyclosporine A and prednisone-associated osteoporosis in heart transplant recipients. J Heart Lung Transplant 1992; 11: 950.
29. Thiebaud D, Krieg MA, Gillard-Berguer D, Jacquet AF, Goy JJ, Burckhardt P,. Cyclosporine induces high bone turnover and may contribute to bone loss after heart transplantation. Eur J Clin Invest 1996; 26: 549.
30. Mazzantini M, Di Munno O, Sinigaglia L, et al. Effect of cyclosporine A on bone density in female rheumatoid arthritis patients: results from a multicenter, cross-sectional study. Clin Exp Rheumatol 2007; 25: 709.
31. Pedreira CC, King E, Jones G, et al. Oral cyclosporin plus topical corticosteroid therapy diminishes bone mass in children with eczema. Pediatr Dermatol 2007; 24: 613.
32. Movsowitz C, Epstein S, Fallon M, Ismail F, Thomas S,. Cyclosporin-A in vivo produces severe osteopenia in the rat: effect of dose and duration of administration. Endocrinology 1988; 123: 2571.
33. Dempster DW,. Bone histomorphometry in glucocorticoidinduced osteoporosis. J Bone Miner Res 1989; 4: 137.
34. Hofbauer LC, Shui C, Riggs BL, et al. Effects of immunosuppressants on receptor activator of NF-kappaB ligand and osteoprotegerin production by human osteoblastic and coronary artery smooth muscle cells. Biochem Biophys Res Commun 2001; 280: 334.
35. Wald NJ, Watt HC, Law MR, Weir DG, McPartlin J, Scott JM,. Homocysteine and ischemic heart disease: results of a prospective study with implications regarding prevention. Arch Intern Med 1998; 158: 862.
36. Shojaie M, Naghshvar F, Izadi HR, Eshraghian A, Pourahmad M,. Homocysteine level in Iranian patients with premature acute myocardial infarction. Chin Med J 2009; 122: 1952.
37. Mudd SH, Levy HL, Kraus JP,. Disorders of transsulfuration. In:, Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease. New York: McGraw-Hill; 2001: 2007-2056.
38. Mudd SH, Skovby F, Levy HL, Pettigrew KD, Wilcken B, Pyeritz RE,. The natural history of homocystinuria due to cystathionine β-synthase deficiency. Am J Hum Genet 1985; 37: 1.
39. Cagnacci A, Baldassari F, Rivolta G, Arangino S, Volpe A,. Relation of homocysteine, folate, and vitamin B12 to bone mineral density of postmenopausal women. Bone 2003; 33: 956.
40. Bucciarelli P, Martini G, Martinelli I, et al. The relationship between plasma homocysteine levels and bone mineral density in post-menopausal women. Eur J Intern Med 2010; 21: 301.
41. Roblin X, Phelip JM, Genevois M, Ducros V, Bonaz B,. Hyperhomocysteinemia is associated with osteoporosis in patients with Crohn's disease. Aliment Pharmacol Ther 2007; 25: 797.
42. Biagini MR, Tozzi A, Bongini E, et al. Association of plasma homocysteine with bone mineral density in postmenopausal women withosteoporosis or osteopenia affected by primary biliary cirrhosis. J Clin Gastroenterol 2007; 41: 635. (Pubitemid 46956523)
43. Alley RA, Chen EL, Beyer TD, Prinz RA,. Does homocysteine contribute to bone disease in hyperparathyroidism? Am J Surg 2008; 195: 374.
44. McLean RR, Jacques PF, Selhub J, et al. Plasma B vitamins, homocysteine, and their relation with bone loss and hip fracture in elderly men and women. J Clin Endocrinol Metab 2008; 93: 2206.
45. Azizi ZA, Zamani A, Omrani LR, et al. Effects of hyperhomocysteinemia during the gestational period on ossification in rat embryo. Bone 2010; 46: 1344.
46. Khan M, Yamauchi M, Srisawasdi S, et al. Homocysteine decreases chondrocyte-mediated matrix mineralization in differentiating chick limb-bud mesenchymal cell micromass cultures. Bone 2001; 28: 387.
47. Lubec B, Fang-Kircher S, Lubec T, Blom HJ, Boers GH,. Evidence of McKusick's hypothesis of deficient collagen cross-linking in patients with homocystinuria. Biochim Biophys Acta 1996; 1315: 159.
48. Sakamoto W, Isomura H, Fujie K, et al. Homocysteine attenuates the expression of osteocalcin but enhances osteopontin in MC373-E1 preosteoblastic cells. Biochim Biophys Acta 2005; 1740: 12.
49. Herrmann M, Widmann T, Colaianni G, Colucci S, Zallone A, Herrmann W,. Increased osteoclast activity in the presence of increased homocysteine concentrations. Clin Chem 2005; 51: 2348.
50. Golbahar J, Hamidi A, Aminzadeh MA, Omrani GR,. Association of plasma folate, plasma total homocysteine, but not methylenetetrahydrofolate reductase C667T polymorphism, with bone mineral density in postmenopausal Iranian women: a cross-sectional study. Bone 2004; 35: 760.
51. Tyagi N, Kandel M, Munjal C, et al. Homocysteine mediated decrease in bone blood flow and remodeling: role of folic acid. J Orthop Res 2011; 29: 1511.
52. Weinstein RS,. Clinical practice. Glucocorticoid-induced bone disease. N Engl J Med 2011; 365: 62.